Xueyan Liu
Fuzhou, 350112, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Integrated Microbiome and Metabolomics Analysis Reveals That Ganoderma lucidum Triterpenoids Ameliorate Colitis Associated with the Modulation of the Gut Microbiota and Metabolic Profiles.
Journal: Foods (Basel, Switzerland)
Published: April 28, 2026
Design, synthesis, and biological evaluation of pyranone-carbamate hybrids as selective butyrylcholinesterase inhibitors with anti-neuroinflammatory activity for Alzheimer's disease.
Journal: Bioorganic chemistry
Published: February 25, 2026
Ganoderma lucidum spore oil with Ganoderma lucidum and Ganoderma sinense extracts (G2SO) shows antitumor and Immunomodulatory effects in mice.
Journal: Scientific reports
Published: September 01, 2025
AI-driven discovery of brain-penetrant Galectin-3 inhibitors for Alzheimer's disease therapy.
Journal: Pharmacological research
Published: February 10, 2025
A novel carbamate-based hybrid derivative with anti-neuroinflammatory properties as a selective butyrylcholinesterase inhibitor for Alzheimer's disease therapy.
Journal: Bioorganic chemistry
Published: January 25, 2025
The Nutritional Composition, Functional Properties, and Food Application of Adlay (Coix lacryma-Jobi L.): A Comprehensive Review.
Journal: Comprehensive reviews in food science and food safety
Published: January 06, 2025
Compound (E)-2-(3,4-dihydroxystyryl)-3-hydroxy-4H-pyran-4-one downregulation of Galectin-3 ameliorates Aβ pathogenesis-induced neuroinflammation in 5 × FAD mice.
Journal: Life sciences
Published: July 11, 2024
Novel anti-neuroinflammatory pyranone-carbamate derivatives as selective butyrylcholinesterase inhibitors for treating Alzheimer's disease.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: February 16, 2024
Regulation of Nrf2/GPX4 Signaling Pathway by Hyperbaric Oxygen Protects Against Depressive Behavior and Cognitive Impairment in a Spinal Cord Injury Rat Model.
Journal: CNS neuroscience & therapeutics
Published: February 01, 2024
The compound (E)-2-(3,4-dihydroxystyryl)-3-hydroxy-4H-pyran-4-one alleviates neuroinflammation and cognitive impairment in a mouse model of Alzheimer's disease.
Journal: Neural regeneration research
Published: November 18, 2023
Novel neuroprotective pyromeconic acid derivatives with concurrent anti-Aβ deposition, anti-inflammatory, and anti-oxidation properties for treatment of Alzheimer's disease.
Journal: European journal of medicinal chemistry
Published: November 21, 2022
Synthesis and properties of the kojic acid dimer and its potential for the treatment of Alzheimer's disease.
Journal: RSC medicinal chemistry
Published: October 20, 2022
Last Updated: 09/26/2026